Overview

A Safety, Tolerability and Efficacy Study of E7070 in Patients With Renal Cell Carcinoma

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if E7070 is a safe and effective treatment for cancer of the kidneys.
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Inc.
Treatments:
N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide